$SONT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Echo Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Echo Therapeutics, Inc.. Get notifications about new insider transactions in Echo Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 23 2017 | SONT | Echo Therapeutics, ... | GOLDBERG MICHAEL M | Grant | A | 0.00 | 25,000 | 0 | 39,500 | 14.5 K to 39.5 K (+172.41 %) | |
Mar 23 2017 | SONT | Echo Therapeutics, ... | GOLDBERG SHEPARD M | Grant | A | 0.00 | 25,000 | 0 | 32,250 | 7.3 K to 32.3 K (+344.83 %) | |
Mar 22 2017 | SONT | Echo Therapeutics, ... | SCHOENBART ALAN WAYNE | CEO, CFO AND SECRET ... | Option Exercise | A | 0.16 | 500,000 | 80,000 | 500,000 | |
Mar 22 2017 | SONT | Echo Therapeutics, ... | SCHOENBART ALAN WAYNE | CEO, CFO AND SECRET ... | Grant | A | 0.00 | 100,000 | 0 | 174,500 | 74.5 K to 174.5 K (+134.23 %) |
Mar 22 2017 | SONT | Echo Therapeutics, ... | SCHOENBART ALAN WAYNE | CEO, CFO AND SECRET ... | Payment of Exercise | F | 0.34 | 28,000 | 9,520 | 74,500 | 102.5 K to 74.5 K (-27.32 %) |
Mar 03 2016 | SONT | Echo Therapeutics, ... | Hollander Scott Wayne | PRESIDENT AND CEO | Option Exercise | A | 1.12 | 175,000 | 196,000 | 58,333 | |
Mar 03 2016 | SONT | Echo Therapeutics, ... | Hollander Scott Wayne | PRESIDENT AND CEO | Grant | A | 0.00 | 150,000 | 0 | 158,000 | 8 K to 158 K (+1,875.00 %) |
Mar 03 2016 | SONT | Echo Therapeutics, ... | GOLDBERG SHEPARD M | Option Exercise | A | 1.12 | 150,000 | 168,000 | 37,500 | ||
Mar 03 2016 | SONT | Echo Therapeutics, ... | GOLDBERG MICHAEL M | Option Exercise | A | 1.12 | 150,000 | 168,000 | 37,500 | ||
Mar 03 2016 | SONT | Echo Therapeutics, ... | SCHOENBART ALAN WAYNE | CFO AND SECRETARY | Option Exercise | A | 1.12 | 150,000 | 168,000 | 50,000 | |
Mar 03 2016 | SONT | Echo Therapeutics, ... | SCHOENBART ALAN WAYNE | CFO AND SECRETARY | Grant | A | 0.00 | 100,000 | 0 | 102,500 | 2.5 K to 102.5 K (+4,000.00 %) |
Mar 03 2016 | SONT | Echo Therapeutics, ... | Edelman Elazer R | Option Exercise | A | 1.12 | 150,000 | 168,000 | 37,500 | ||
May 20 2015 | SONT | Echo Therapeutics, ... | SCHOENBART ALAN WAYNE | CFO AND SECRETARY | Buy | P | 1.44 | 2,500 | 3,600 | 2,500 | 0 to 2.5 K |
May 20 2015 | SONT | Echo Therapeutics, ... | Hollander Scott Wayne | PRESIDENT AND CEO | Buy | P | 1.48 | 8,000 | 11,840 | 8,000 | 0 to 8 K |
Jan 12 2015 | SONT | Echo Therapeutics, ... | GOLDBERG SHEPARD M | Option Exercise | A | 1.62 | 150,000 | 243,000 | 150,000 | ||
Jan 12 2015 | SONT | Echo Therapeutics, ... | GOLDBERG MICHAEL M | Option Exercise | A | 1.62 | 150,000 | 243,000 | 150,000 | ||
Dec 22 2014 | SONT | Echo Therapeutics, ... | Nordlicht Mark | 10% Owner | Option Exercise | P | 3.00 | 1 | 3 | 1 | |
Dec 22 2014 | SONT | Echo Therapeutics, ... | Nordlicht Mark | 10% Owner | Option Exercise | P | 0.00 | 420,168 | 0 | 420,168 | |
Jul 14 2014 | SONT | Echo Therapeutics, ... | GOLDBERG SHEPARD M | Option Exercise | A | 2.11 | 28,000 | 59,080 | 28,000 | ||
Jul 14 2014 | SONT | Echo Therapeutics, ... | GOLDBERG SHEPARD M | Grant | A | 0.00 | 7,250 | 0 | 7,250 | 0 to 7.3 K | |
Jul 01 2014 | SONT | Echo Therapeutics, ... | Nordlicht Mark | 10% Owner | Buy | P | 2.20 | 55,083 | 121,183 | 678,452 | 623.4 K to 678.5 K (+8.84 %) |
Jul 01 2014 | SONT | Echo Therapeutics, ... | Nordlicht Mark | 10% Owner | Buy | P | 2.20 | 10,656 | 23,443 | 623,369 | 612.7 K to 623.4 K (+1.74 %) |
Jun 27 2014 | SONT | Echo Therapeutics, ... | Nordlicht Mark | 10% Owner | Buy | P | 2.20 | 15,000 | 33,000 | 612,713 | 597.7 K to 612.7 K (+2.51 %) |
Jun 27 2014 | SONT | Echo Therapeutics, ... | Nordlicht Mark | 10% Owner | Buy | P | 2.20 | 2,300 | 5,060 | 597,713 | 595.4 K to 597.7 K (+0.39 %) |
Jun 24 2014 | SONT | Echo Therapeutics, ... | Nordlicht Mark | 10% Owner | Buy | P | 2.20 | 386 | 849 | 595,413 | 595 K to 595.4 K (+0.06 %) |
Jun 24 2014 | SONT | Echo Therapeutics, ... | Nordlicht Mark | 10% Owner | Buy | P | 2.20 | 85 | 187 | 595,027 | 594.9 K to 595 K (+0.01 %) |
Jun 24 2014 | SONT | Echo Therapeutics, ... | Nordlicht Mark | 10% Owner | Buy | P | 2.20 | 16,490 | 36,271 | 594,942 | 578.5 K to 594.9 K (+2.85 %) |
Mar 17 2014 | SONT | Echo Therapeutics, ... | GOLDBERG MICHAEL M | Option Exercise | A | 3.19 | 56,000 | 178,640 | 56,000 | ||
Mar 17 2014 | SONT | Echo Therapeutics, ... | GOLDBERG MICHAEL M | Grant | A | 0.00 | 14,500 | 0 | 14,500 | 0 to 14.5 K | |
Jan 03 2014 | SONT | Echo Therapeutics, ... | SMITH JAMES FRANCIS | Option Exercise | A | 2.98 | 56,000 | 166,880 | 60,500 | ||
Jan 03 2014 | SONT | Echo Therapeutics, ... | SMITH JAMES FRANCIS | Grant | A | 0.00 | 14,500 | 0 | 22,900 | 8.4 K to 22.9 K (+172.62 %) | |
Jan 03 2014 | SONT | Echo Therapeutics, ... | GRIECO WILLIAM | Option Exercise | A | 2.98 | 56,000 | 166,880 | 60,500 | ||
Jan 03 2014 | SONT | Echo Therapeutics, ... | GRIECO WILLIAM | Grant | A | 0.00 | 14,500 | 0 | 38,200 | 23.7 K to 38.2 K (+61.18 %) | |
Jan 03 2014 | SONT | Echo Therapeutics, ... | ENRIGHT VINCENT D | Option Exercise | A | 2.98 | 56,000 | 166,880 | 70,500 | ||
Jan 03 2014 | SONT | Echo Therapeutics, ... | ENRIGHT VINCENT D | Grant | A | 0.00 | 14,500 | 0 | 28,200 | 13.7 K to 28.2 K (+105.84 %) | |
Dec 12 2013 | SONT | Echo Therapeutics, ... | Nordlicht Mark | 10% Owner | Option Exercise | P | 2.75 | 1 | 3 | 1 | |
Dec 12 2013 | SONT | Echo Therapeutics, ... | Nordlicht Mark | 10% Owner | Option Exercise | P | 2.75 | 1 | 3 | 1 | |
Dec 12 2013 | SONT | Echo Therapeutics, ... | Nordlicht Mark | 10% Owner | Option Exercise | P | 0.00 | 349,723 | 0 | 349,723 | |
Dec 12 2013 | SONT | Echo Therapeutics, ... | Nordlicht Mark | 10% Owner | Option Exercise | P | 0.00 | 1,398,890 | 0 | 1,398,890 | |
Dec 12 2013 | SONT | Echo Therapeutics, ... | Nordlicht Mark | 10% Owner | Buy | P | 2.75 | 13,914 | 38,264 | 578,452 | 564.5 K to 578.5 K (+2.46 %) |
Dec 12 2013 | SONT | Echo Therapeutics, ... | Nordlicht Mark | 10% Owner | Buy | P | 2.75 | 55,655 | 153,051 | 507,824 | 452.2 K to 507.8 K (+12.31 %) |
Oct 02 2013 | SONT | Echo Therapeutics, ... | ENRIGHT VINCENT D | Option Exercise | A | 2.76 | 1,500 | 4,140 | 14,500 | ||
Oct 02 2013 | SONT | Echo Therapeutics, ... | ENRIGHT VINCENT D | Grant | A | 0.00 | 400 | 0 | 13,700 | 13.3 K to 13.7 K (+3.01 %) | |
Oct 02 2013 | SONT | Echo Therapeutics, ... | SMITH JAMES FRANCIS | Option Exercise | A | 2.76 | 1,500 | 4,140 | 4,500 | ||
Oct 02 2013 | SONT | Echo Therapeutics, ... | SMITH JAMES FRANCIS | Grant | A | 0.00 | 400 | 0 | 8,400 | 8 K to 8.4 K (+5.00 %) | |
Oct 02 2013 | SONT | Echo Therapeutics, ... | GRIECO WILLIAM | Option Exercise | A | 2.76 | 1,500 | 4,140 | 4,500 | ||
Oct 02 2013 | SONT | Echo Therapeutics, ... | GRIECO WILLIAM | Grant | A | 0.00 | 400 | 0 | 23,700 | 23.3 K to 23.7 K (+1.72 %) | |
Oct 02 2013 | SONT | Echo Therapeutics, ... | Doman Robert F | EXEC. CHAIRMAN AND ... | Option Exercise | A | 2.76 | 1,500 | 4,140 | 4,500 | |
Oct 02 2013 | SONT | Echo Therapeutics, ... | Doman Robert F | EXEC. CHAIRMAN AND ... | Grant | A | 0.00 | 400 | 0 | 4,700 | 4.3 K to 4.7 K (+9.30 %) |
Jul 02 2013 | SONT | Echo Therapeutics, ... | Doman Robert F | Option Exercise | A | 2.49 | 1,500 | 3,735 | 16,500 | ||
Jul 02 2013 | SONT | Echo Therapeutics, ... | Doman Robert F | Grant | A | 0.00 | 400 | 0 | 39,400 | 39 K to 39.4 K (+1.03 %) | |
Jul 02 2013 | SONT | Echo Therapeutics, ... | SMITH JAMES FRANCIS | Option Exercise | A | 2.49 | 1,500 | 3,735 | 16,500 | ||
Jul 02 2013 | SONT | Echo Therapeutics, ... | SMITH JAMES FRANCIS | Grant | A | 0.00 | 400 | 0 | 76,400 | 76 K to 76.4 K (+0.53 %) | |
Jul 02 2013 | SONT | Echo Therapeutics, ... | GRIECO WILLIAM | Option Exercise | A | 2.49 | 1,500 | 3,735 | 16,500 | ||
Jul 02 2013 | SONT | Echo Therapeutics, ... | GRIECO WILLIAM | Grant | A | 0.00 | 400 | 0 | 229,400 | 229 K to 229.4 K (+0.17 %) | |
Jul 02 2013 | SONT | Echo Therapeutics, ... | ENRIGHT VINCENT D | Option Exercise | A | 2.49 | 1,500 | 3,735 | 116,500 | ||
Jul 02 2013 | SONT | Echo Therapeutics, ... | ENRIGHT VINCENT D | Grant | A | 0.00 | 400 | 0 | 129,400 | 129 K to 129.4 K (+0.31 %) | |
Apr 11 2013 | SONT | Echo Therapeutics, ... | GRIECO WILLIAM | Option Exercise | A | 0.79 | 15,000 | 11,850 | 15,000 | ||
Apr 11 2013 | SONT | Echo Therapeutics, ... | SMITH JAMES FRANCIS | Option Exercise | A | 0.79 | 15,000 | 11,850 | 15,000 | ||
Apr 11 2013 | SONT | Echo Therapeutics, ... | Doman Robert F | Option Exercise | A | 0.79 | 15,000 | 11,850 | 15,000 | ||
Apr 10 2013 | SONT | Echo Therapeutics, ... | Doman Robert F | Grant | A | 0.00 | 4,000 | 0 | 39,000 | 35 K to 39 K (+11.43 %) | |
Apr 11 2013 | SONT | Echo Therapeutics, ... | ENRIGHT VINCENT D | Option Exercise | A | 0.79 | 15,000 | 11,850 | 115,000 | ||
Apr 10 2013 | SONT | Echo Therapeutics, ... | SMITH JAMES FRANCIS | Grant | A | 0.00 | 4,000 | 0 | 76,000 | 72 K to 76 K (+5.56 %) | |
Apr 10 2013 | SONT | Echo Therapeutics, ... | GRIECO WILLIAM | Grant | A | 0.00 | 4,000 | 0 | 229,000 | 225 K to 229 K (+1.78 %) | |
Apr 10 2013 | SONT | Echo Therapeutics, ... | ENRIGHT VINCENT D | Grant | A | 0.00 | 4,000 | 0 | 129,000 | 125 K to 129 K (+3.20 %) | |
Mar 25 2013 | SONT | Echo Therapeutics, ... | Doman Robert F | Buy | P | 0.80 | 15,000 | 11,961 | 35,000 | 20 K to 35 K (+75.00 %) | |
Mar 22 2013 | SONT | Echo Therapeutics, ... | GRIECO WILLIAM | Buy | P | 0.76 | 30,000 | 22,779 | 225,000 | 195 K to 225 K (+15.38 %) | |
Mar 14 2013 | SONT | Echo Therapeutics, ... | Doman Robert F | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K | |
Jan 11 2013 | SONT | Echo Therapeutics, ... | SMITH JAMES FRANCIS | Grant | A | 0.00 | 6,250 | 0 | 72,000 | 65.8 K to 72 K (+9.51 %) | |
Jan 11 2013 | SONT | Echo Therapeutics, ... | ENRIGHT VINCENT D | Grant | A | 0.00 | 6,250 | 0 | 208,334 | 202.1 K to 208.3 K (+3.09 %) | |
Jan 11 2013 | SONT | Echo Therapeutics, ... | GRIECO WILLIAM | Grant | A | 0.00 | 6,250 | 0 | 195,000 | 188.8 K to 195 K (+3.31 %) | |
Oct 26 2012 | SONT | Echo Therapeutics, ... | MOONEY PATRICK T | CEO AND PRESIDENT | Grant | A | 0.00 | 150,000 | 0 | 2,025,000 | 1.9 M to 2 M (+8.00 %) |
Oct 26 2012 | SONT | Echo Therapeutics, ... | BURKE KIMBERLY A | GENERAL COUNSEL | Grant | A | 0.00 | 37,500 | 0 | 325,000 | 287.5 K to 325 K (+13.04 %) |
Oct 26 2012 | SONT | Echo Therapeutics, ... | BURKE KIMBERLY A | GENERAL COUNSEL | Grant | A | 0.00 | 37,500 | 0 | 287,500 | 250 K to 287.5 K (+15.00 %) |
Oct 26 2012 | SONT | Echo Therapeutics, ... | SCHNITTKER CHRISTOPHER P. | CFO | Grant | A | 0.00 | 31,250 | 0 | 125,000 | 93.8 K to 125 K (+33.33 %) |
Oct 26 2012 | SONT | Echo Therapeutics, ... | SCHNITTKER CHRISTOPHER P. | CFO | Grant | A | 0.00 | 31,250 | 0 | 93,750 | 62.5 K to 93.8 K (+50.00 %) |
Oct 02 2012 | SONT | Echo Therapeutics, ... | GRIECO WILLIAM | Grant | A | 0.00 | 6,250 | 0 | 188,750 | 182.5 K to 188.8 K (+3.42 %) | |
Oct 02 2012 | SONT | Echo Therapeutics, ... | ENRIGHT VINCENT D | Grant | A | 0.00 | 6,250 | 0 | 202,084 | 195.8 K to 202.1 K (+3.19 %) | |
Oct 02 2012 | SONT | Echo Therapeutics, ... | SMITH JAMES FRANCIS | Grant | A | 0.00 | 6,250 | 0 | 65,750 | 59.5 K to 65.8 K (+10.50 %) | |
Aug 23 2012 | SONT | Echo Therapeutics, ... | SMITH JAMES FRANCIS | Buy | P | 1.47 | 6,400 | 9,408 | 59,500 | 53.1 K to 59.5 K (+12.05 %) | |
Aug 23 2012 | SONT | Echo Therapeutics, ... | SMITH JAMES FRANCIS | Buy | P | 1.47 | 13,600 | 19,992 | 53,100 | 39.5 K to 53.1 K (+34.43 %) | |
Jul 03 2012 | SONT | Echo Therapeutics, ... | GRIECO WILLIAM | Grant | A | 0.00 | 6,250 | 0 | 182,500 | 176.3 K to 182.5 K (+3.55 %) | |
Jul 03 2012 | SONT | Echo Therapeutics, ... | ENRIGHT VINCENT D | Grant | A | 0.00 | 6,250 | 0 | 195,834 | 189.6 K to 195.8 K (+3.30 %) | |
Jul 03 2012 | SONT | Echo Therapeutics, ... | SMITH JAMES FRANCIS | Grant | A | 0.00 | 6,250 | 0 | 39,500 | 33.3 K to 39.5 K (+18.80 %) | |
May 31 2012 | SONT | Echo Therapeutics, ... | MOONEY PATRICK T | CEO AND PRESIDENT | Gift | G | 0.00 | 625,907 | 0 | 1,875,000 | 2.5 M to 1.9 M (-25.03 %) |
May 01 2012 | SONT | Echo Therapeutics, ... | MOONEY PATRICK T | CEO AND PRESIDENT | Grant | A | 0.00 | 150,000 | 0 | 2,500,907 | 2.4 M to 2.5 M (+6.38 %) |
May 01 2012 | SONT | Echo Therapeutics, ... | BURKE KIMBERLY A | GENERAL COUNSEL | Grant | A | 0.00 | 37,500 | 0 | 250,000 | 212.5 K to 250 K (+17.65 %) |
May 01 2012 | SONT | Echo Therapeutics, ... | SCHNITTKER CHRISTOPHER P. | CFO | Grant | A | 0.00 | 31,250 | 0 | 62,500 | 31.3 K to 62.5 K (+100.00 %) |
Jan 31 2012 | SONT | Echo Therapeutics, ... | BURKE KIMBERLY A | GENERAL COUNSEL | Grant | A | 0.00 | 37,500 | 0 | 212,500 | 175 K to 212.5 K (+21.43 %) |
Jan 31 2012 | SONT | Echo Therapeutics, ... | SCHNITTKER CHRISTOPHER P. | CFO | Grant | A | 0.00 | 31,250 | 0 | 31,250 | 0 to 31.3 K |
Jan 31 2012 | SONT | Echo Therapeutics, ... | MOONEY PATRICK T | CEO AND PRESIDENT | Grant | A | 0.00 | 150,000 | 0 | 2,350,907 | 2.2 M to 2.4 M (+6.82 %) |
May 18 2011 | SONT | Echo Therapeutics, ... | SCHNITTKER CHRISTOPHER P. | CFO | Option Exercise | A | 4.09 | 200,000 | 818,000 | 200,000 | |
Mar 02 2011 | SONT | Echo Therapeutics, ... | Mitchell Harry | CFO AND COO | Grant | A | 0.00 | 100,000 | 0 | 516,187 | 416.2 K to 516.2 K (+24.03 %) |
Mar 02 2011 | SONT | Echo Therapeutics, ... | MOONEY PATRICK T | CEO AND PRESIDENT | Grant | A | 0.00 | 350,000 | 0 | 2,200,907 | 1.9 M to 2.2 M (+18.91 %) |
Mar 09 2011 | SONT | Echo Therapeutics, ... | ENRIGHT VINCENT D | Grant | A | 0.00 | 50,000 | 0 | 183,334 | 133.3 K to 183.3 K (+37.50 %) | |
Feb 18 2011 | SONT | Echo Therapeutics, ... | GRIECO WILLIAM | Grant | A | 0.00 | 20,000 | 0 | 170,000 | 150 K to 170 K (+13.33 %) | |
Feb 18 2011 | SONT | Echo Therapeutics, ... | SMITH JAMES FRANCIS | Grant | A | 0.00 | 20,000 | 0 | 27,000 | 7 K to 27 K (+285.71 %) | |
Apr 30 2010 | SONT | Echo Therapeutics, ... | LANGER ROBERT | Director | Grant | A | 1.28 | 64,844 | 83,000 | 603,450 | 538.6 K to 603.5 K (+12.04 %) |
Jan 30 2008 | SONT | Echo Therapeutics, ... | WIGLEY MICHAEL | Director | Option Exercise | D | 0.00 | 133,334 | 0 | 66,666 | |
Jan 30 2008 | SONT | Echo Therapeutics, ... | WIGLEY MICHAEL | Director | Sell | D | 0.00 | 11,250 | 0 | 803,130 | 814.4 K to 803.1 K (-1.38 %) |
Mar 27 2008 | SONT | Echo Therapeutics, ... | ENRIGHT VINCENT D | Director | Option Exercise | A | 1.55 | 50,000 | 77,500 | 50,000 | |
Dec 27 2007 | SONT | Echo Therapeutics, ... | WIGLEY MICHAEL | Director | Option Exercise | A | 1.39 | 200,000 | 278,000 | 200,000 | |
Dec 27 2007 | SONT | Echo Therapeutics, ... | Witoshkin Walter W | Director | Option Exercise | A | 1.39 | 200,000 | 278,000 | 200,000 | |
Dec 27 2007 | SONT | Echo Therapeutics, ... | Singh Shawn | President (interim) | Option Exercise | A | 1.39 | 500,000 | 695,000 | 500,000 | |
Dec 27 2007 | SONT | Echo Therapeutics, ... | MOONEY PATRICK T | Chief Executive Off ... | Option Exercise | A | 1.39 | 500,000 | 695,000 | 500,000 | |
Dec 27 2007 | SONT | Echo Therapeutics, ... | Mitchell Harry | Chief Operating Off ... | Option Exercise | A | 1.39 | 300,000 | 417,000 | 300,000 | |
Dec 27 2007 | SONT | Echo Therapeutics, ... | LANGER ROBERT | Director | Option Exercise | A | 1.39 | 100,000 | 139,000 | 100,000 | |
Sep 17 2007 | SONT | Echo Therapeutics, ... | Mitchell Harry | Chief Operating Off ... | Option Exercise | A | 2.39 | 250,000 | 597,500 | 250,000 | |
Sep 17 2007 | SONT | Echo Therapeutics, ... | MOONEY PATRICK T | Chief Executive Off ... | Option Exercise | A | 2.39 | 500,000 | 1,195,000 | 500,000 | |
Sep 17 2007 | SONT | Echo Therapeutics, ... | MOONEY PATRICK T | Chief Executive Off ... | Grant | A | 0.00 | 625,907 | 0 | 625,907 | 0 to 625.9 K |
Sep 17 2007 | SONT | Echo Therapeutics, ... | Singh Shawn | President (Interim) | Option Exercise | A | 2.39 | 500,000 | 1,195,000 | 500,000 | |
Sep 17 2007 | SONT | Echo Therapeutics, ... | Singh Shawn | President (Interim) | Grant | A | 0.00 | 625,907 | 0 | 625,907 | 0 to 625.9 K |
Jun 18 2007 | SONT | Echo Therapeutics, ... | WIGLEY MICHAEL | Director | Option Exercise | P | 1.40 | 30,000 | 42,000 | 30,000 | |
Jun 18 2007 | SONT | Echo Therapeutics, ... | WIGLEY MICHAEL | Director | Buy | P | 1.00 | 100,000 | 100,000 | 814,380 | 714.4 K to 814.4 K (+14.00 %) |
Jun 18 2007 | SONT | Echo Therapeutics, ... | Mitchell Harry | Interim CEO and CFO | Option Exercise | P | 1.40 | 1,500 | 2,100 | 1,500 | |
Jun 18 2007 | SONT | Echo Therapeutics, ... | Mitchell Harry | Interim CEO and CFO | Buy | P | 1.00 | 5,000 | 5,000 | 55,000 | 50 K to 55 K (+10.00 %) |
May 24 2007 | SONT | Echo Therapeutics, ... | AMARAL JOSEPH | Director | Option Exercise | A | 1.33 | 25,000 | 33,250 | 25,000 | |
May 24 2007 | SONT | Echo Therapeutics, ... | LANGER ROBERT | Director | Option Exercise | A | 1.33 | 25,000 | 33,250 | 25,000 | |
May 24 2007 | SONT | Echo Therapeutics, ... | PUORRO GERARD E | Director | Option Exercise | A | 1.33 | 25,000 | 33,250 | 25,000 | |
May 24 2007 | SONT | Echo Therapeutics, ... | WIGLEY MICHAEL | Director | Option Exercise | A | 1.33 | 50,000 | 66,500 | 50,000 | |
May 24 2007 | SONT | Echo Therapeutics, ... | Witoshkin Walter W | Director | Option Exercise | A | 1.33 | 25,000 | 33,250 | 25,000 | |
Mar 15 2007 | SONT | Echo Therapeutics, ... | Mitchell Harry | Interim CEO and CFO | Option Exercise | A | 1.54 | 25,000 | 38,500 | 25,000 | |
Feb 16 2007 | SONT | Echo Therapeutics, ... | Witoshkin Walter W | Director | Option Exercise | A | 0.62 | 50,000 | 31,000 | 50,000 | |
Feb 01 2007 | SONT | Echo Therapeutics, ... | WIGLEY MICHAEL | Director | Option Exercise | P | 0.21 | 150,000 | 31,500 | 150,000 | |
Feb 01 2007 | SONT | Echo Therapeutics, ... | WIGLEY MICHAEL | Director | Buy | P | 0.10 | 600,000 | 60,000 | 714,380 | 114.4 K to 714.4 K (+524.57 %) |
Jan 31 2007 | SONT | Echo Therapeutics, ... | KOHLER GARY S | Director | Option Exercise | P | 0.21 | 25,000 | 5,250 | 25,000 | |
Jan 31 2007 | SONT | Echo Therapeutics, ... | KOHLER GARY S | Director | Buy | P | 0.10 | 100,000 | 10,000 | 180,448 | 80.4 K to 180.4 K (+124.30 %) |
Jan 31 2007 | SONT | Echo Therapeutics, ... | LANGER ROBERT | Director | Option Exercise | P | 0.21 | 62,500 | 13,125 | 62,500 | |
Jan 31 2007 | SONT | Echo Therapeutics, ... | LANGER ROBERT | Director | Buy | P | 0.10 | 250,000 | 25,000 | 307,504 | 57.5 K to 307.5 K (+434.75 %) |
Jan 31 2007 | SONT | Echo Therapeutics, ... | Mitchell Harry | Interim CEO | Option Exercise | P | 0.21 | 12,500 | 2,625 | 12,500 | |
Jan 31 2007 | SONT | Echo Therapeutics, ... | Mitchell Harry | Interim CEO | Buy | P | 0.10 | 50,000 | 5,000 | 50,000 | 0 to 50 K |
Jan 31 2007 | SONT | Echo Therapeutics, ... | PUORRO GERARD E | Director | Option Exercise | P | 0.21 | 50,000 | 10,500 | 50,000 | |
Jan 31 2007 | SONT | Echo Therapeutics, ... | PUORRO GERARD E | Director | Buy | P | 0.10 | 200,000 | 20,000 | 212,500 | 12.5 K to 212.5 K (+1,600.00 %) |
Jan 04 2007 | SONT | Echo Therapeutics, ... | Marston Barry | VP of Sales & Marke ... | Sell | D | 0.00 | 20,000 | 0 | 3,094 | 23.1 K to 3.1 K (-86.60 %) |
Jan 04 2007 | SONT | Echo Therapeutics, ... | DAVISON THOMAS W | Acting President an ... | Sell | D | 0.00 | 65,000 | 0 | 13,825 | 78.8 K to 13.8 K (-82.46 %) |
Jan 04 2007 | SONT | Echo Therapeutics, ... | Mitchell Harry | Interim CEO and Act ... | Option Exercise | A | 0.21 | 150,000 | 31,500 | 150,000 | |
Jan 04 2007 | SONT | Echo Therapeutics, ... | Mitchell Harry | Interim CEO and Act ... | Sell | D | 0.00 | 42,000 | 0 | 0 | 42 K to 0 (-100.00 %) |
Sep 19 2006 | SONT | Echo Therapeutics, ... | Mitchell Harry | CFO and Treasurer | Grant | A | 0.00 | 42,000 | 0 | 42,000 | 0 to 42 K |
Aug 16 2006 | SONT | Echo Therapeutics, ... | DAVISON THOMAS W | President and CEO | Grant | A | 0.00 | 140,000 | 0 | 153,825 | 13.8 K to 153.8 K (+1,012.66 %) |
Aug 16 2006 | SONT | Echo Therapeutics, ... | Marston Barry | VP of Sales & Marke ... | Grant | A | 0.00 | 20,000 | 0 | 23,094 | 3.1 K to 23.1 K (+646.41 %) |
Aug 16 2006 | SONT | Echo Therapeutics, ... | AMARAL JOSEPH | Director | Grant | A | 0.00 | 7,500 | 0 | 7,750 | 250 to 7.8 K (+3,000.00 %) |
Aug 16 2006 | SONT | Echo Therapeutics, ... | KOHLER GARY S | Director | Grant | A | 0.00 | 7,500 | 0 | 80,448 | 72.9 K to 80.4 K (+10.28 %) |
Aug 16 2006 | SONT | Echo Therapeutics, ... | LANGER ROBERT | Director | Grant | A | 0.00 | 7,500 | 0 | 57,504 | 50 K to 57.5 K (+15.00 %) |
Aug 16 2006 | SONT | Echo Therapeutics, ... | PUORRO GERARD E | Director | Grant | A | 0.00 | 7,500 | 0 | 12,500 | 5 K to 12.5 K (+150.00 %) |
Aug 16 2006 | SONT | Echo Therapeutics, ... | SULLIVAN BRIAN F | Director | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
Aug 16 2006 | SONT | Echo Therapeutics, ... | WIGLEY MICHAEL | Director | Grant | A | 0.00 | 15,000 | 0 | 114,380 | 99.4 K to 114.4 K (+15.09 %) |
May 25 2006 | SONT | Echo Therapeutics, ... | KOHLER GARY S | Director | Option Exercise | A | 0.25 | 25,000 | 6,250 | 25,000 | |
May 25 2006 | SONT | Echo Therapeutics, ... | AMARAL JOSEPH | Director | Option Exercise | A | 0.25 | 25,000 | 6,250 | 25,000 | |
May 25 2006 | SONT | Echo Therapeutics, ... | PUORRO GERARD E | Director | Option Exercise | A | 0.25 | 25,000 | 6,250 | 25,000 | |
May 25 2006 | SONT | Echo Therapeutics, ... | LANGER ROBERT | Director | Option Exercise | A | 0.25 | 25,000 | 6,250 | 25,000 |